Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
Mal-PEG8-Val-Cit-PAB-MMAE,Cas:2353409-69-3
Mal-PEG8-Val-Cit-PAB-MMAE
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-M-3010 | 5mg | 850.00 | + Add to cart |
|
| R-M-3010 | 10mg | 1459.00 | + Add to cart |
|
|
|
||||
Product description
Mal-PEG8-Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate. It contains a maleimide PEG8 moiety, a protease-sensitive Val-Cit dipeptide, a PABC linker and a MMAE payload. The MMAE is a synthetic antineoplastic agent. It can be attached to a monoclonal antibody (MAB) which directs it toward cancer cells. Mal is reactive with thiol group of antibody.
| Appearance | N/A |
|---|---|
| Molecular weight | N/A |
| Purity | >90% |
| Solubility | N/A |
| Cas | 2353409-69-3 |
| Molecular formula | C81H131N11O23 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds of Mal-PEG8-Val-Cit-PAB-MMAE Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
